Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 236-813-4 | CAS number: 13494-80-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Link to relevant study records
- Endpoint:
- genetic toxicity in vitro, other
- Remarks:
- genotoxic properties were investigated using a non-validated high-throughput screening (gH2AX assay) in two human cell lines (HepG2 and LS-174T)
- Type of information:
- experimental study
- Adequacy of study:
- other information
- Study period:
- no information
- Reliability:
- other: genotoxic properties were investigated using a non-validated high-throughput screening (gH2AX assay) in two human cell lines (HepG2 and LS-174T)
- Rationale for reliability incl. deficiencies:
- other: genotoxic properties were investigated using a non-validated high-throughput screening (gH2AX assay) in two human cell lines (HepG2 and LS-174T)
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- The genotoxic and cytotoxic properties of different heavy metals were investigated using a non-validated high-throughput screening (gH2AX assay) in two human cell lines (HepG2 and LS-174T).
HepG2 and LS174-T cells cultured in aMEM Medium (10% FBS, 100 U/mL penicillin and 100 mg/mL streptomycin) were seeded in 96-well microplates at a density of 3.23 x10E4 cells per well, 16 h prior to treatment. After 16 h, the medium was replaced by 90 mL of medium without serum. Next, 10 mL of metalloids solubilized in pure water were placed directly in the treated well. Cells were incubated for 24 h with different range of concentration for each metalloid depending on its solubility and cytotoxicity: 1, 10, 100, 500, 1000 µM for K2TeO3.
The positive control used for each treatment was 1 µM benzo[a]pyrene (BaP). The negative control was pure water (10% v/v final concentration).
Briefly, after the treatment, cells were fixed and DNA and gH2AX were visualized using the In-Cell Western technique (ICW assay). - GLP compliance:
- not specified
- Type of assay:
- other: High-throughput screening (gH2AX assay)
- Specific details on test material used for the study:
- Heavy metals (purity>95%) were purchased from Sigma-Aldrich (Saint Quentin Fallavier, France). All stock solutions were prepared in pure water (10X) (EMD Millipore ElixTM Essential 5 Water Purification System)
- Target gene:
- The phosphorylation of histone H2AX (gH2AX) was determined as an early and sensitive marker of genotoxicity induced by different types of DNA lesions including notably DNA adducts, DNA abasic sites, DNA strand breaks and DNA replication or transcription blocking lesions and including those hypothesized to be induced by heavy metals.
- Species / strain / cell type:
- mammalian cell line, other: HepG2 human hepatoblastoma cells
- Details on mammalian cell type (if applicable):
- ATCC N° HB-8065
Cells were cultured in aMEM medium supplemented with 10% FBS, 100 U/mL penicillin and 100 mg/mL streptomycin. Cultures were maintained in a humidified atmosphere with 5% CO2 at 37°C and the medium was refreshed every 2–3 days during subculturing. - Additional strain / cell type characteristics:
- not specified
- Species / strain / cell type:
- mammalian cell line, other: LS-174T human epithelial colorectal adenocarcinoma cell
- Details on mammalian cell type (if applicable):
- ATCC N° CL-188
Cells were cultured in aMEM medium supplemented with 10% FBS, 100 U/mL penicillin and 100 mg/mL streptomycin. Cultures were maintained in a humidified atmosphere with 5% CO2 at 37°C and the medium was refreshed every 2–3 days during subculturing. - Additional strain / cell type characteristics:
- not specified
- Metabolic activation:
- without
- Test concentrations with justification for top dose:
- depending on its solubility and cytotoxicity: 1, 10, 100, 500, 1000 µM
- Vehicle / solvent:
- pure water
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- benzo(a)pyrene
- Details on test system and experimental conditions:
- HepG2 and LS174-T cells cultured in aMEM Medium (10% FBS, 100 U/mL penicillin and 100 mg/mL streptomycin, maintained in a humidified atmosphere with 5 % CO2 at 37 °C) were seeded in 96-well microplates at a density of 3.23 x10E4 cells per well, 16 h prior to treatment. After 16 h, the medium was replaced by 90 µL of medium without serum. Next, 10 µL of metalloids solubilized in pure water were placed directly in the treated well. Cells were incubated for 24 h with different range of concentration for each metalloid depending on its solubility and cytotoxicity: 1, 10, 100, 500, 1000 µM for K2TeO3.
The positive control used for each treatment was 1 µM benzo[a]pyrene (BaP). The negative control was pure water (10% v/v final concentration).
All experiments were performed independently at least three times.
After the treatment, cells were anaylsed using the In-Cell Western technique (ICW). Briefly, after the treatment cells were fixed with 4% paraformaldehyde in phosphate buffered saline (PBS) and permeabilized with 0.2% Triton X-100. The cells were then incubated with a blocking solution followed by incubation with anti-gH2AX rabbit monoclonal primary antibody (Clone 20E3, Cell signaling) in PST buffer. After 2 h of incubation at room temperature and three washes, secondary detection was carried out using an infrared fluorescent dye combined with goat antibody (CF770, Biotium). For DNA labeling, RedDot2 (Biotium) was used in combination with the secondary antibody. After 1 h of incubation, DNA and gH2AX were visualized using an Odyssey Infrared Imaging Scanner.
To determine cytotoxicity, the DNA content (related to the number of cells) recorded in the treated cells was compared to the DNA content in the control cells and is expressed as relative cell count (% RCC). - Rationale for test conditions:
- Study design is based on validation of high-throughput genotoxicity assay screening using gammaH2AX in-cell western assay on HepG2 cells and other publications using the same or similar test conditions.
- Evaluation criteria:
- Genotoxicity was considered positive only if three criteria were all fulfilled: (1) The compound caused a 1.3-fold increase in gH2AX, (2) there was a statistically significant difference compared to controls and (3) a level of cytotoxicity below 50% of the controls was observed.
- Statistics:
- The genotoxicity of each metalloid was compared with the results obtained with the controls, using Student’s test with Excel 2016 software (*P<0.05; **P<0.01; ***P<0.001). Error bars represent SEM (standard error of the mean).
- Species / strain:
- mammalian cell line, other: HepG2 cells
- Metabolic activation:
- without
- Genotoxicity:
- positive
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- not specified
- Remarks:
- results of negative control are not shown
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- not specified
- Remarks:
- results of positive control are not shown
- Species / strain:
- mammalian cell line, other: LS-174T cells
- Metabolic activation:
- without
- Genotoxicity:
- positive
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- not specified
- Remarks:
- results of negative control are not shown
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- not specified
- Remarks:
- results of positive control are not shown
- Additional information on results:
- Response of HepG2 Cells:
Cytotoxicity was observed from 100 µM and 500 µM for K2TeO3. A satistically significant increase was observed at 500 and 1000 µM, which was linked with marked cytotoxicity. At 500 µM K2TeO3 induced a more than 1.5-fold increase in gH2AX of 1.60 +/- 0.8 with RCC (%): 61+/- 30.
Responses of LS-174T Cells:
The genotoxic effects of the metalloids that tested positive in HepG2 cells was confirmed in the LS-174T cell line with a similar concentration-dependent induction of gH2AX at subtoxic concentrations. A satistically significant increase was observed at 500 and 1000 µM, which was linked with marked cytotoxicity. At 500 µM K2TeO3 induced gH2AX fold induction of 1.37 +/- 0.23 with an RCC (%) of 69+/-11.
Conclusively, K2TeO3 induced an increasing concentration-response of gH2AX with marked cytotoxicity at the highest concentrations tested. Thereby, K2TeO3 was exceeding the threshold for positivity at a concentration showing marked cytotoxicity already. - Conclusions:
- K2TeO3 was found to induce an increasing concentration-response of gH2AX and marked cytotoxicity at the highest concentrations tested in the two human cell lines HepG2 and LS-174T. The investigated heavy metals tested positive in this assay were ranked based on their gentoxic potency as indicated by the lowest observed adverse effect concentration. Thereby, K2TeO3 was in second last position as K2TeO3 was only slightly exceeding the non-validated threshold value (1.3 fold) for positivity (1.37 fold in LS-174T cells) and at this concentration marked cytotoxicty (RCC 69 %) was observed already.
- Executive summary:
In this study, the genotoxic and cytotoxic properties of 11 different heavy metals were investigated using high-throughput screening (gH2AX assay) in two human cell lines (HepG2 and LS-174T).
HepG2 and LS174-T cells were seeded in 96-well microplates at a density of 3.23 x10E4 cells per well, 16 h prior to treatment. After 16 h, the medium was replaced by 90 µL of medium without serum. Next, 10 µL of metalloids solubilized in pure water were placed directly in the treated well. Cells were incubated for 24 h with different range of concentration for each metalloid depending on its solubility and cytotoxicity: 1, 10, 100, 500, 1000 µM for K2TeO3. The positive control used for each treatment was 1 µM benzo[a]pyrene (BaP). The negative control was pure water (10% v/v final concentration). However, the results for positive and negative controls were not shown.
Briefly, after the treatment, cells were fixed and DNA and gH2AX were visualized using the In-Cell Western technique (ICW assay).
K2TeO3 was found to induce an increasing concentration-response of gH2AX and marked cytotoxicity at the highest concentrations tested in the two human cell lines HepG2 and LS-174T. The investigated heavy metals tested positive in this assay were ranked based on their gentoxic potency as indicated by the lowest observed adverse effect concentration. Thereby, K2TeO3 was in second last position as K2TeO3 was only slightly exceeding the non-validated threshold value (1.3 fold) for positivity (1.37 fold in LS-174T cells) and at this concentration marked cytotoxicty (RCC 69 %) was observed already.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Ames Test:
In a reverse gene mutation assay in bacteria according to OECD guideline 471, strains TA 1535, TA 1537, TA98 and TA100 of S. typhimurium and E. coli WP2uvrA were exposed to Tellurium, (powder 99.95 % a.i.), at concentrations up to 5000 µg/plate in the presence and absence of mammalian metabolic activation, (S9 mix; phenobarbital/β-naphthoflavone induced rat liver).
Tellurium had no mutagenic activity in the bacterium tester strains under the test conditions used in this study.
Chromosomal Aberration Test with Tellurium dioxide
The read-across substance Tellurium dioxide was tested according to OECD guideline 479 in vitro in a Chromosome Aberration Assay using Chinese hamster V79 lung cells . The test item was examined up to the cytotoxic concentrations according to the relevant OECD guideline covering the range from cytotoxicity to no or little cytotoxicity.
Treatment with the test item did not result in a repeatable, statistically and biologically significant increase in the frequency of the cells with structural chromosome aberrations without gaps either in the presence or absence of a metabolic activation system.
Mammalian Cell Gene Mutation Test with Tellurium dioxide:
An in vitro mammalian cell assay according to OECD Guideline 476 was performed in mouse lymphoma L5178Y TK+/- cells at the tk locus to test the potential of Tellurium dioxide to cause gene mutation and/or chromosome damage. Treatment was performed for 3 hours with and without metabolic activation (±S9 mix) and for 24 hours without metabolic activation. The evaluated concentration ranges covered the range from cytotoxicity to no or little cytotoxicity.
Statistical significant increase was observed, however taking into account the global evaluation factor no biological relevant mutagenic effect of tellurium dioxid, was found either in the presence or in the absence of metabolic activation system under the conditions of this Mouse Lymphoma Assay.
Justification for read-across is outlined in document attached to section 13 of the dossier.
Justification for selection of genetic toxicity endpoint
Reliable data are available from the full in-vitro test set required under REACH regulation.
Short description of key information:
Negative data are available from a gene mutation assay in bacteria with tellurium. As well negative data were obtained from a chromosomal aberration test and a mammalian cell gene mutation assay with the read-across substance tellurium dioxide.
Negative data are available from a gene mutation assay in bacteria with tellurium. As well negative data were obtained from a chromosomal aberration test and a mammalian cell gene mutation assay with the read-across substance tellurium dioxide.
Tellurium was subject to CLH process in 2019 and 2020. The RAC in its assessment and comparison with the classification criteria agrees that no indication for a mutagenic potential of neither tellurium nor tellurium dioxide can be derived from the presented in vitro studies.
On this basis and in the absence of any in vivo study, no classification for germ cell mutagenicity was proposed by RAC.
See RAC opinion CLH-O-0000006810-77-01/F adopted 11 June 2020 for detailed explanation
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Based on all available information the substance is devoid of any relevant genotoxic potency.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.